Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B To

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Leukemia|April 1, 1997
Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemiaI D Lewis, D N Haylock, S Moore, et al.
Bone Marrow Transplantation|July 1, 1996
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseasesM M Roberts, P G Dyson, K Willson, et al.
British Journal of Haematology|December 1, 1985
Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapyC A Juttner, L B To, D N Haylock, et al.
Bone Marrow Transplantation|June 1, 1987
Immune reconstitution following peripheral blood stem cell autograftingL B To, C A Juttner, F Stomski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancerR L Basser, R Abraham, L B To, et al.
International Journal of Laboratory Hematology|January 16, 2009
The presence of leukaemia-associated phenotypes is an independent predictor of induction failure in acute myeloid leukaemiaA Al-Mawali, L B To, D Gillis, et al.
Blood|January 15, 1998
Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cellsI D Lewis, L A McDiarmid, L M Samels, et al.
The Medical Journal of Australia|September 21, 1987
Successful peripheral blood stem-cell autograft with a near-critical dose of myeloid progenitor cells in acute non-lymphoblastic leukaemia in relapseC A Juttner, L B To, J Q Ho, et al.
Australian and New Zealand Journal of Medicine|December 1, 1992
A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancerP A Rowlings, J L Bayly, C M Rawling, et al.
Cytokine|December 21, 2010
Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patientsG Hodge, J Scott, M Osborn, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Leukemia|April 1, 1997
Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemiaI D Lewis, D N Haylock, S Moore, et al.
Bone Marrow Transplantation|July 1, 1996
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseasesM M Roberts, P G Dyson, K Willson, et al.
British Journal of Haematology|December 1, 1985
Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapyC A Juttner, L B To, D N Haylock, et al.
Bone Marrow Transplantation|June 1, 1987
Immune reconstitution following peripheral blood stem cell autograftingL B To, C A Juttner, F Stomski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancerR L Basser, R Abraham, L B To, et al.
International Journal of Laboratory Hematology|January 16, 2009
The presence of leukaemia-associated phenotypes is an independent predictor of induction failure in acute myeloid leukaemiaA Al-Mawali, L B To, D Gillis, et al.
Blood|January 15, 1998
Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cellsI D Lewis, L A McDiarmid, L M Samels, et al.
The Medical Journal of Australia|September 21, 1987
Successful peripheral blood stem-cell autograft with a near-critical dose of myeloid progenitor cells in acute non-lymphoblastic leukaemia in relapseC A Juttner, L B To, J Q Ho, et al.
Australian and New Zealand Journal of Medicine|December 1, 1992
A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancerP A Rowlings, J L Bayly, C M Rawling, et al.
Cytokine|December 21, 2010
Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patientsG Hodge, J Scott, M Osborn, et al.
Pageof 12